BioLineRx is a late clinical-stage biopharmaceutical development company that focuses on oncology.
Industries BiotechnologyMedical DeviceOncologyTherapeuticsHeadquarters Regions Europe, Middle East, and Africa (EMEA), Middle East Founded Date 2003 Founders Morris Laster Operating Status Active Last Funding Type Post-IPO Equity Legal Name BiolineRx Ltd.
Stock Symbol NASDAQ:BLRX Company Type For Profit
Contact Email info@BioLineRx.com Phone Number +972 2-548-9100
BioLineRx is a clinical-stage, publicly traded (NASDAQ/ TASE: BLRX) biopharmaceutical development company based in Jerusalem, Israel. The Company develops products suitable for the pharmaceutical market satisfying an unmet medical need or exhibiting advantages over current therapies.